Literature DB >> 9171912

Fluoxetine-induced Raynaud's phenomenon.

A Rudnick1, I Modai, A Zelikovski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171912     DOI: 10.1016/s0006-3223(97)00188-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  7 in total

1.  Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod.

Authors:  Raffaela Bertoli; François Girardin; Stefan Russmann; Bernhard H Lauterburg
Journal:  Eur J Clin Pharmacol       Date:  2003-01-29       Impact factor: 2.953

2.  Citalopram-induced Raynaud's phenomenon.

Authors:  A M Peiró; C Margarit; M Torra
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

Review 3.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

Review 4.  Advances in the treatment of Raynaud's phenomenon.

Authors:  Terri L Levien
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

Review 5.  Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies.

Authors:  Iqra Nawaz; Yashfa Nawaz; Eisha Nawaz; Muhammad Romail Manan; Adil Mahmood
Journal:  Cureus       Date:  2022-01-28

6.  Microvascular Hand Surgery for Digital Ischemia in Scleroderma.

Authors:  Ellen S Satteson; Melody P Chung; Lorinda S Chung; James Chang
Journal:  J Scleroderma Relat Disord       Date:  2019-06-29

7.  Risperidone Related Raynaud's Phenomenon: An Adolescent Case.

Authors:  Serkan Güneş; Özalp Ekinci; Halenur Teke; Veli Yıldırım
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-02-28       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.